Neuro65/AOCN2024

Presentation information

Print

Oral Session

English

[O-02] Oral Session 02 ［English］「Gene therapy, Regenerative medicine, and Therapy development」

Wed. May 29, 2024 3:35 PM - 5:05 PM Room6 (Hall D7, D Block, 7F, TIF)

Chair(s): Tetsuya Nagata (NucleoTIDE and PepTIDE Drug Discovery Center, Tokyo Medical and Dental University, Japan), Yohei Okada (Institute for Medical Science of Aging, Aichi Medical University, Japan)

[O-02-1] Antisense oligonucleotide for spinocerebellar ataxia type 31

Miwa Higashi1, Michi Okita1, Takashi Ishii1, Hanako Aoki1, Takao Shoji2, Yoshiyuki Onishi2, Tetsuya Nagata1, Makoto Koizumi2, Kinya Ishikawa3, Takanori Yokota1 (1.Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan, 2.Modality Research Laboratories, Daiichi Sankyo Co., Ltd., Japan, 3.Center for Personalized Medicine for Healthy Aging, Medical School Hospital, Tokyo Medical and Dental University, Japan)

Abstract password authentication.
You can find the password on page 15 of the program book.

Password